132 related articles for article (PubMed ID: 14609280)
61. Voltammetric determination of tyrosine based on an L-serine polymer film electrode.
Li C
Colloids Surf B Biointerfaces; 2006 Jul; 50(2):147-51. PubMed ID: 16797945
[TBL] [Abstract][Full Text] [Related]
62. Adsorptive stripping voltammetric behavior and determination of anticholinergic agent oxybutynin chloride on a mercury electrode.
Jain R; Radhapyari K; Jadon N
J Colloid Interface Sci; 2007 Oct; 314(2):572-7. PubMed ID: 17618643
[TBL] [Abstract][Full Text] [Related]
63. Adsorptive cathodic stripping voltammetric assay of the estrogen drug ethinylestradiol in pharmaceutical formulation and human plasma at a mercury electrode.
Ghoneim EM; El-Desoky HS; Ghoneim MM
J Pharm Biomed Anal; 2006 Feb; 40(2):255-61. PubMed ID: 16146680
[TBL] [Abstract][Full Text] [Related]
64. Electrochemistry and voltammetric determination of colchicine using an acetylene black-dihexadecyl hydrogen phosphate composite film modified glassy carbon electrode.
Zhang H
Bioelectrochemistry; 2006 May; 68(2):197-201. PubMed ID: 16122990
[TBL] [Abstract][Full Text] [Related]
65. Adsorptive stripping voltammetric determination of triprolidine hydrochloride in pharmaceutical tablets.
Zayed SI; Habib IH
Farmaco; 2005; 60(6-7):621-5. PubMed ID: 15950226
[TBL] [Abstract][Full Text] [Related]
66. Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV.
Al-Rimawi F
Talanta; 2009 Oct; 79(5):1368-71. PubMed ID: 19635372
[TBL] [Abstract][Full Text] [Related]
67. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection.
Mandrioli R; Mercolini L; Cesta R; Fanali S; Amore M; Raggi MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):88-94. PubMed ID: 17581798
[TBL] [Abstract][Full Text] [Related]
68. Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS.
Massaroti P; Cassiano NM; Duarte LF; Campos DR; Marchioretto MA; Bernasconi G; Calafatti S; Barros FA; Meurer EC; Pedrazzoli J
J Pharm Pharm Sci; 2005 Aug; 8(2):340-7. PubMed ID: 16124946
[TBL] [Abstract][Full Text] [Related]
69. Electrochemical behavior and determination of amiloride drug in bulk form and pharmaceutical formulation at mercury electrodes.
El-Hefnawy GB; El-Hallag IS; Ghoneim EM; Ghoneim MM
J Pharm Biomed Anal; 2004 Mar; 34(5):899-907. PubMed ID: 15019024
[TBL] [Abstract][Full Text] [Related]
70. Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form.
Shaikh KA; Patil SD; Devkhile AB
J Pharm Biomed Anal; 2008 Dec; 48(5):1481-4. PubMed ID: 18993009
[TBL] [Abstract][Full Text] [Related]
71. Validation of uv derivative spectrophotometric method for determination of benazepril hydrochloride in tablets and evaluation of its stability.
Stanisz B; Paszun S; Leśniak M
Acta Pol Pharm; 2009; 66(4):343-9. PubMed ID: 19702164
[TBL] [Abstract][Full Text] [Related]
72. Osteryoung square wave stripping voltammetry at mercury film electrode for monitoring ultra trace levels of Tarabine PFS and its interaction with ssDNA.
Abd El-Hady D; Abdel-Hamid MI; Seliem MM; Andrisano V; Abo El-Maali N
J Pharm Biomed Anal; 2004 Mar; 34(5):879-90. PubMed ID: 15019022
[TBL] [Abstract][Full Text] [Related]
73. Voltammetric determination of montelukast sodium in dosage forms and human plasma.
Alsarra I; Al-Omar M; Gadkariem EA; Belal F
Farmaco; 2005; 60(6-7):563-7. PubMed ID: 15925367
[TBL] [Abstract][Full Text] [Related]
74. Development of HPLC method coupled with fluorescence detection for simultaneous determination of donepezil HCl and trazodone HCl in spiked human plasma and tablets dosage forms.
Ragab GH; Bahgat EA
Ann Pharm Fr; 2019 Jul; 77(4):286-294. PubMed ID: 31027753
[TBL] [Abstract][Full Text] [Related]
75. Assay of fluoxetine hydrochloride by titrimetric and HPLC methods.
Bueno F; Bergold AM; Fröehlich PE
Boll Chim Farm; 2000; 139(6):256-9. PubMed ID: 11213431
[TBL] [Abstract][Full Text] [Related]
76. Chiral HPLC method for chiral purity determination of paroxetine drug substance.
Zukowski J; Brightwell M; De Biasi V
Chirality; 2003 Aug; 15(7):600-4. PubMed ID: 12840824
[TBL] [Abstract][Full Text] [Related]
77. Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma.
Shin JG; Kim KA; Yoon YR; Cha IJ; Kim YH; Shin SG
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):452-6. PubMed ID: 9746264
[TBL] [Abstract][Full Text] [Related]
78. An HPLC method for the indirect quantification of a quinone adduct of the drug paroxetine.
Zukowski J; Bryant D; Camilleri P
Acta Pol Pharm; 2006; 63(3):175-9. PubMed ID: 20085221
[TBL] [Abstract][Full Text] [Related]
79. Electroanalytical characteristics of piribedil and its differential pulse and square wave voltammetric determination in pharmaceuticals and human serum.
Uslu B; Ozkan SA
J Pharm Biomed Anal; 2003 Mar; 31(3):481-9. PubMed ID: 12615235
[TBL] [Abstract][Full Text] [Related]
80. Method development and validation for the HPLC assay (potency and related substances) for 20 mg paroxetine tablets.
Lambropoulos J; Spanos GA; Lazaridis NV
J Pharm Biomed Anal; 1999 Apr; 19(5):793-802. PubMed ID: 10698543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
